Purpose <p>This study described the presenting features, initial assessment, hospital care, and complications at discharge among Australian adolescents and young adults with Invasive meningococcal disease (IMD).</p> Methods <p>We conducted a retrospective study of IMD cases aged 15–25 years admitted between 2005 and 2018 in ten Australian hospitals.</p> Results <p>A total of 104 IMD cases were included; 95.2% were due to serogroup B, and the mean age was 19.3 years (SD 2.1). Initial assessment most commonly occurred in the emergency department following self-presentation/private transport (50.0%), followed by general practice (32.4%) and paramedic-led pre-hospital care (17.7%). The most common nonspecific presenting symptoms were headache (80.8%), vomiting or nausea (75.0%), and fever (72.1%), and category 3 was the most frequently assigned triage level (40.6%). Half of cases required ICU admission (50.0%), with a mean ICU stay of 2.8 days (SD 2.4). Compared with patients who self-presented to the emergency department, initial assessment by paramedics in the community was associated with higher odds of ICU admission (adjusted AOR 4.42, 95% CI 1.81 to 16.5). A delay of more than 1&#xa0;day between symptom onset and first medical presentation was associated with higher odds of discharge with one or more complications (aOR 2.88, 95% CI 1.13 to 7.35). At discharge, 43.3% had at least one complication, most commonly neurological sequelae (55.6% of those with complications), and 2 cases (1.9%) died.</p> Conclusion <p>Delayed presentation was associated with a higher risk of IMD complications, highlighting the importance of early assessment and timely management to improve outcomes.</p> Clinical trial registration <p>Clinicaltrails.gov, NCT03798574, <a href="https://clinicaltrials.gov/study/NCT03798574">https://clinicaltrials.gov/study/NCT03798574</a>.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults

  • Mark McMillan,
  • Hassen Mohammed,
  • Jim Buttery,
  • Margaret Angliss,
  • Belinda Barton,
  • Christopher C. Blyth,
  • Suja M. Mathew,
  • Morgyn S. Warner,
  • Renjy Nelson,
  • Rory Hannah,
  • Naomi Runnegar,
  • Helen Siobhan Marshall

摘要

Purpose

This study described the presenting features, initial assessment, hospital care, and complications at discharge among Australian adolescents and young adults with Invasive meningococcal disease (IMD).

Methods

We conducted a retrospective study of IMD cases aged 15–25 years admitted between 2005 and 2018 in ten Australian hospitals.

Results

A total of 104 IMD cases were included; 95.2% were due to serogroup B, and the mean age was 19.3 years (SD 2.1). Initial assessment most commonly occurred in the emergency department following self-presentation/private transport (50.0%), followed by general practice (32.4%) and paramedic-led pre-hospital care (17.7%). The most common nonspecific presenting symptoms were headache (80.8%), vomiting or nausea (75.0%), and fever (72.1%), and category 3 was the most frequently assigned triage level (40.6%). Half of cases required ICU admission (50.0%), with a mean ICU stay of 2.8 days (SD 2.4). Compared with patients who self-presented to the emergency department, initial assessment by paramedics in the community was associated with higher odds of ICU admission (adjusted AOR 4.42, 95% CI 1.81 to 16.5). A delay of more than 1 day between symptom onset and first medical presentation was associated with higher odds of discharge with one or more complications (aOR 2.88, 95% CI 1.13 to 7.35). At discharge, 43.3% had at least one complication, most commonly neurological sequelae (55.6% of those with complications), and 2 cases (1.9%) died.

Conclusion

Delayed presentation was associated with a higher risk of IMD complications, highlighting the importance of early assessment and timely management to improve outcomes.

Clinical trial registration

Clinicaltrails.gov, NCT03798574, https://clinicaltrials.gov/study/NCT03798574.